N

Nibec Co Ltd
KOSDAQ:138610

Watchlist Manager
Nibec Co Ltd
KOSDAQ:138610
Watchlist
Price: 38 250 KRW -3.41% Market Closed
Market Cap: 434.5B KRW

Wall Street
Price Targets

Price Targets Summary
Nibec Co Ltd

There are no price targets for Nibec Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Nibec Co Ltd Competitors:
Price Targets
CRBU
Caribou Biosciences Inc
560% Upside
SVRA
Savara Inc
64% Upside
ENTA
Enanta Pharmaceuticals Inc
18% Upside
SPRB
Spruce Biosciences Inc
154% Upside
GNFT
Genfit SA
71% Upside
FDMT
4D Molecular Therapeutics Inc
317% Upside
AUPH
Aurinia Pharmaceuticals Inc
5% Upside
ABBV
Abbvie Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Nibec Co Ltd

For the last 13 years the compound annual growth rate for Nibec Co Ltd's revenue is 18%. The projected CAGR for the next 13 years is 15%.

18%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nibec Co Ltd

Operating Income forecast
is not available for
Nibec Co Ltd

Net Income
Forecast

Net Income Estimate
Nibec Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nibec Co Ltd's stock price target?
Not Available

Nibec Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Nibec Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 13 years the compound annual growth rate for Nibec Co Ltd's revenue is 18%. The projected CAGR for the next 13 years is 15%.

Back to Top